The price you pay for Epidiolex may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the ...

UK-based GW Pharmaceuticals’ Epidiolex looks on course for approval in the US, after a panel of FDA experts unanimously backed it as a treatment for two rare forms of epilepsy. The FDA's ...

GW Pharmaceuticals is closing in on a US filing for its cannabinoid epilepsy drug, Epidiolex, after trumpeting late-stage study findings. The company specialises in drugs derived from the cannabis ...

Professor O’Sullivan’s presentation, “A Cannabidiol Cocrystal (ART12.11) Tablet Has Comparable Pharmacokinetics to Epidiolex,” highlighted results from canine studies evaluating Artelo’s ...

Although Epidiolex can cause adverse effects, including elevated liver enzymes, fatigue, and possible infections, investigators say that it is usually better tolerated than antipsychotic medications.

GW contributed $991 million to Jazz's overall 2024 revenue, largely driven by its leading product, Epidiolex. This drug is a cannabidiol for the treatment of severe, rare forms of epilepsy.

The presentation will showcase Artelo’s recently obtained pharmacokinetic results in canine studies with the Company’s proprietary oral solid compositions of ART12.11 compared to Epidiolex.